Ubiquitin Conjugating Enzyme E2 H (UBE2H) Is Linked to Poor Outcomes and Metastasis in Lung Adenocarcinoma
The prognosis of patients with metastatic lung adenocarcinoma (LUAD) is poor. Although novel lung cancer treatments have been developed for metastatic LUAD, not all patients are fit to receive these treatments. The present study aimed to identify the novel regulatory genes in metastatic LUAD. Becaus...
Main Authors: | Meng-Chi Yen, Kuan-Li Wu, Yu-Wei Liu, Yung-Yun Chang, Chao-Yuan Chang, Jen-Yu Hung, Ying-Ming Tsai, Ya-Ling Hsu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Biology |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-7737/10/5/378 |
Similar Items
-
Predictive Potential of Circulating Ube2h mRNA as an E2 Ubiquitin-Conjugating Enzyme for Diagnosis or Treatment of Alzheimer’s Disease
by: Key-Hwan Lim, et al.
Published: (2020-05-01) -
Ubiquitin-conjugating enzyme E2C (UBE2C) is a prognostic indicator for cholangiocarcinoma
by: Khaa Hoo Ong, et al.
Published: (2023-12-01) -
The ubiquitin conjugating enzyme Ube2W regulates solubility of the Huntington's disease protein, huntingtin
by: Bo Wang, et al.
Published: (2018-01-01) -
Expression and Effect of Inhibition of the Ubiquitin-Conjugating Enzyme E2C on Esophageal Adenocarcinoma
by: Jules Lin, et al.
Published: (2006-12-01) -
The UBE2D ubiquitin conjugating enzymes: Potential regulatory hubs in development, disease and evolution
by: Monica Roman-Trufero, et al.
Published: (2022-12-01)